Omnicell (OMCL) Gains from Sales and Divestitures (2010 - 2026)
Omnicell (OMCL) posted Gains from Sales and Divestitures of -$117,000 for Q2 2026, compared with -$181,000 a year earlier.
Powered by 
Analysis
Omnicell (OMCL) Gains from Sales and Divestitures (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Omnicell was -$435,000; for FY2025, it was -$488,000.
- In prior years, Omnicell's Gains from Sales and Divestitures was -$978,000 in FY2024, -$2.57 million in FY2023, -$678,000 in FY2022 and -$433,000 in FY2021.
- Quarterly Gains from Sales and Divestitures has run from a low of -$1.12 million in Q3 2023 to a high of -$39,000 in Q1 2024 over five years.
- According to Business Quant data, Gains from Sales and Divestitures for the three prior quarters was -$122,000 (Q1 2026), -$80,000 (Q4 2025) and -$116,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn |
| 10 | Omnicell | 1.53 Bn | 624.56 Mn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -117,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -80,000.00 |
| Sep 30, 2025 | -116,000.00 |
| Jun 30, 2025 | -181,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Dec 31, 2024 | -566,000.00 |
| Sep 30, 2024 | -191,000.00 |
| Jun 30, 2024 | -182,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Dec 31, 2023 | -462,000.00 |
| Sep 30, 2023 | -1.12 Mn |
| Jun 30, 2023 | -191,000.00 |
| Mar 31, 2023 | -802,000.00 |
| Dec 31, 2022 | -347,000.00 |
| Sep 30, 2022 | -331,000.00 |
| Dec 31, 2021 | -136,000.00 |
| Dec 31, 2020 | -267,000.00 |
| Dec 31, 2019 | -9,000.00 |
| Sep 30, 2019 | -37,000.00 |
API Access
Omnicell Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=OMCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "OMCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=OMCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();